Dengue Vaccine Market Size, Share, Research Report Forecast 2024
The report "Dengue Vaccine Market by Product Type (CYD-TDV (Dengvaxia), DENVax, TetraVax-DV, Others), by Vaccine Type (Live Attenuated Vaccine, Killed Vaccine, Others), By End User (Hospitals, Clinics, Government Institutes, Non-Governmental Organizations (NGOs)) - Global Forecasts to 2030", is projected to reach USD 472.6 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 12.8% during the forecast period 2024-2030. The growth of the dengue vaccine market is majorly driven by the growing incidence of dengue and growing research and development activities.